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Abstract 
Background: A prototype risk assessment suite (FACE-CARAS) was developed for 
use within CAMHS and evaluated for acceptability and reliability.  
Method: Clinicians underwent brief training in the system and invited 69 young 
people to an assessment using the FACE-CARAS. A second rater produced a separate 
set of blind ratings for most patients. Clinicians also provided qualitative feedback. 
Results: The component schedules of the FACE-CARAS could be reliably rated with 
‘near perfect’ to ‘moderate’ agreement observed. Internal reliability-consistency 
values, as indexed by Cronbach’s alpha, were moderate to high in all cases. 
Conclusions: The assessment schedules that make up the FACE-CARAS can be 
reliably rated by clinicians with minimal training. 
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Young people affected by mental health issues frequently present with indicators of 
increased risk to either themselves  or others (McArthur Foundation Research 
Network on Mental Health and the Law, 1996; Monahan et al., 2000; Tiffin & 
Kaplan, 2004). Despite this scenario, a comprehensive risk assessment system for use 
in Child and Adolescent Mental Health Services (CAMHS) is not currently available 
(Borum, Bartel, & Forth, 2003; Tiffin & Nadkarni, 2010; Tiffin & Richardson, 2006). 
Existing risk assessment protocols only assess specific risk domains (e.g. 
interpersonal violence), have been generally developed outwith the UK (Borum et al., 
2003; Forth, Kossen, & Hare, 2003), and tend to focus on adults (Cooper & Tiffin, 
2006). Risk assessment schedules for young people need to account for the 
developmental context and dynamic nature of risk factors. Moreover, risk assessment 
instruments developed in countries with differing levels of baseline violence may not 
be valid (Singh, Fazel, Gueorguieva, & Buchanan, 2014). 
The FACE- Child and Adolescent Risk Assessment Suite (FACE-CARAS) 
consists of nine novel schedules (no schedules were previously licenced or 
copyrighted) designed to address this gap. The suite contains a general ‘Risk Profile’ 
that can be used in conjunction with any of the nine individual schedules; if required, 
more than one schedule can be used per patient. Six of these schedules focus on 
specific risk domains (self-harm, aggression, aggression in psychosis, vulnerability, 
learning disability vulnerability and sexually harmful behaviour) and the remaining 
three schedules focus on specific inpatient settings (eating disorders, low secure and 
open wards). The information collected from these schedules is then summarised and 
used to inform a risk formulation and risk management plan. The content of FACE 
Eating Disorder Schedule (FEDS) was informed by the MARSIPAN Junior guidelines 
(Royal College of Psychiatrists, 2014).  
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After the initial development of the schedules, focus groups were held with 
CAMHS clinicians to provide in-depth feedback on the draft FACE-CARAS (Daniel, 
Weir, & Tiffin, 2013). This feedback suggested that the FACE-CARAS was a 
generally well-structured and clinically acceptable risk assessment suite (Daniel et al., 
2013). The findings were subsequently fed back into the design of the system. The 
current study aimed to assess whether this amended version of the FACE-CARAS 
was a practical and feasible approach to risk assessment in CAMHS. Reliability is a 
necessary, but not sufficient, prerequisite for validity. Therefore, we evaluated the 
reliability of the FACE-CARAS.  
 
Methods 
A mixed quantitative/qualitative methodology was used. The study was conducted 
within Tees, Esk and Wear Valleys (TEWV) NHS Foundation Trust. A favourable 
ethical opinion was obtained from the NRES Northern & Yorkshire and the School of 
Medicine, Pharmacy and Health Ethics Sub-Committee (REC reference: 11NE/0248).  
Clinicians were provided with an hour-long training session, including 
practice vignettes. The FACE-CARAS is completed according to structured 
professional judgement based upon the responses to an initial screen in the Risk 
Profile (Figure 1). Therefore, not all schedules were completed for each participant. 
Each schedule item is rated using between two and five anchor points. For example, 
in the Checklist for Risk of Aggression in Youth (CRAY) one question on ‘Frequency 
of previous aggression’ has four possible anchor points: ‘No problem’, ‘Some 
aggression but less than 4 physically aggressive episodes directed at people per 
year’, ‘Physical aggression towards others occurs on average between 4/year to less 
than once a month’ or ‘Physical aggression towards others occurs at least on average 
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monthly’. In this pilot study, the FACE-CARAS was implemented using a paper 
format.  
Participants were recruited via two methods; an internal audit (using the 
Sexually Harming Adolescent Risk Protocol- 20 Item Version [SHARP20]) or a 
cross-sectional survey using a purposive sampling approach. Eight individuals were 
approached for the internal audit and 64 patients who currently required risk 
assessments (initial, review or discharge) were invited to participate. The sample was 
derived from seven CAMHS teams (forensic, Early Intervention Psychosis [EIP], a 
low secure inpatient, open inpatient, Eating Disorder Unit, and two Tier 3 CAMHS. 
The Learning Disabilities Service [LD] did not receive any qualifying young people 
in the short time frame of the study. Clinicians, at least one from each team, were 
approached via their team managers and asked to use the FACE-CARAS. In some 
assessments, a second rater (either a researcher or another clinician) was present who 
completed risk ratings blind to the main clinicians coding. 
Participant inclusion criteria: 
- an active patient requiring a risk assessment as Trust policy 
-aged 10 to 18 years of age 
-with sufficient English to respond to the questions in the schedules 
-who consents to participate (or, if under 16, assents with parental consent) 
  
 
INSERT FIGURE 1 
Figure 1. Layout of the FACE CARAS 
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Clinicians were asked for feedback on the FACE-CARAS during the study 
and completed an open-ended questionnaire at completion.  
 
Data Analysis 
Analysis was conducted on paired ratings. Inter-rater reliability was reported using the 
average quadratically weighted kappa for each schedule and internal reliability using 
Cronbach’s alpha. A quadratically weighted kappa was utilised to disproportionately 
penalise disagreements that differed by more than one point, reflecting the potential 
clinical implications of disparities in ratings. Cronbach’s alpha was calculated on 
average paired ratings. 
 
Results 
Recruitment 
A total of 69 participants were approached to take part (six were excluded for 
incomplete consent [one refusal]) leaving a total of 63 participants suitable for 
analysis. The mean age of the sample was 15.94 (range 12.23- 18.71) with 36 males; 
two participant’s age and sex were not known due to mis-recorded unique identifiers. 
Data were obtained from 20 participating clinicians and the research assistant. 
 
Schedules 
Risk Profile 
Forty nine were completed (44 paired ratings) from all services except Eating 
Disorders. There were two elements (self-neglect/accidental self-harm) of this 
schedule on which raters (n=2) disagreed by more than one point. 
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The screening checklist was praised as useful for inexperienced members of 
staff, however it was also suggested it would be helpful if more experienced staff 
could bypass this section. The kappa and alpha values for the FACE-CARAS 
schedules are provided in Table 1.  
 
Child & Adolescent Self Harm Schedule (CASH) 
Fourteen were obtained (12 paired) from all services except Eating Disorders and low 
secure. On elements relating to substance use, non-life threatening self-harm, low 
mood/dysphoria and problem solving/ability to cope with stress, one set of raters 
disagreed by two points. Two sets of raters disagreed by two points on the suicidal 
ideation question.  
 
CRAY 
Twenty seven were obtained (22 paired) from forensics, open inpatient and two 
community teams. Questions relating to current weapon use, frequency and intensity 
of aggression, quality of care, peer relationships, empathy, social competency, sibling 
criminal history and educational exclusions each had one set of raters disagree by two 
points. The items relating to previous weapon use, exposure to domestic violence and 
impulsivity had two sets of raters disagree by two points and one set by three points. 
Both items relating to fire-setting and substance use associated with aggression had 
one set of raters disagree by three points. The total of the averaged paired ratings 
scores for the CRAY items was significantly higher for the forensic compared to the 
non-forensic CAMHS patients (χ2=19.36, p<0.001 for inter-group difference on 
Wilcoxon ranked-sum test). This difference was not accounted for by trends in age or 
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sex as the two groups with completed CRAY schedules did not significantly differ in 
these respects. 
 
FEDS 
Ten were completed (all paired) by the Eating Disorders team. No items demonstrated 
marked disagreement. 
 
Learning Disability Vulnerability Assessment Schedule (LDVAS) 
Two were obtained (all paired) from EIP. The majority of the questions demonstrated 
100% agreement between raters. On items relating to physical 
impairments/unrecognised sources of pain and parent/carer antisocial 
traits/behaviour one set of raters disagreed by two points.  
 
Ward Assessment (OPEN)  
Eight were obtained (all paired). No raters disagreed by more than one point.  
 
Schedule for Risk of Aggression in Psychosis (ScRAP) 
Six were obtained (5 paired) from forensic, community and EIP teams. Items relating 
to pre-morbid antisocial personality traits and non-concordance had one set of raters 
disagree by two points. Questions relating to treatment concordance, pre-morbid 
aggression to persons, previous non-concordance, passivity experiences, identified 
triggers to aggression and impaired insight had two sets of raters that disagreed by 
two points.  
 
Ward Assessment (SECURE) 
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Seven were obtained (all paired) from the secure ward.  For the item on absconsion 
risk, two sets of raters disagreed by two points. 
 
SHARP20 
Ten were obtained; two from the pilot, eight from the internal audit (7 paired) all from 
forensics. Items relating to attitudes towards sexually harmful behaviour, sexual 
development status (pre-pubertal) and sexual interests and sexual preferences, one set 
of raters disagreed by two points. On the item relating to the nature of aggression two 
sets of raters disagreed by two points.  
 
Vulnerability Assessment Schedule (VAS) 
Nine were obtained (8 paired) from community teams and forensics. On items relating 
to history of abuse or neglect, geographical mobility and parent/carer antisocial 
traits/behaviour, one set of raters disagreed by two points. On items relating to 
exposure to domestic violence and parent/carer physical health problems, two sets of 
raters disagreed by two points.  
 
INSERT TABLE 1 
 
Table 1: Average quadratically weighted kappa and Cronbach’s alpha values for the 
FACE-CARAS schedules. 
***
 Almost perfect agreement, 
**
 Substantial agreement, 
*
 Moderate agreement 
 
Clinician Feedback 
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Mid-point clinician feedback highlighted inconsistencies between anchor point 
definitions and their corresponding ratings. All such points were corrected in an 
iteration following the completion of this project. At the end of the study, eleven 
clinicians provided further feedback via a questionnaire.  
When asked to describe the overall experience of using the FACE-CARAS 
clinicians described it as “straightforward” (n=2), “functional”, “good” (n=2), “fit 
well with the client group” “excellent learning experience” “easier once practiced a 
few times”, “satisfactory/good means of gathering info”, “useful” “liked the 
structure”, “positive”, “very comprehensive but flexible system”. Some noted “the 
initial assessment form is slightly overpopulated with data”, at times it was “lengthy 
and monotonous” although it was acknowledged that some repetition may be avoided 
via an electronic format. Clinicians reported they would be content to use the system 
in the future but some highlighted they “would be happy to use in clinical practice but 
not in paper form” and “will need to be incorporated into the [Trust electronic 
records] system”. When asked if they experienced any problems using the FACE-
CARAS most clinicians did not report any problems. However, some responded that 
the initial FACE-CARAS initial screening schedule could be “streamlined more”, 
“time, however, merely a teething problem”, “some of the items could have been 
weighted differently to denote different levels of risk”, “feel the initial screening 
questions section too lengthy”. When asked what impressed them the most about the 
FACE-CARAS responses included “gives a clear/overall picture of clinical risk 
without collecting too much information”, “breadth and depth of information 
covered”, “clear anchor points”, “ease of use”, “comprehensive nature of the tool”, 
“very in-depth assessment once completed”, “comprehensive, helped lead risk-based 
discussion”, “how it encourages a thorough consideration of all aspects of a patients 
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situation”, “objectivity”, “comprehensive with client group”, “clinically relevant” and 
“it was clearly and logically set out”. All participating staff agreed that electronic 
implementation of the system would be likely to quicken assessment and avoid the 
need for duplicate entries. One concern raised was that the pilot was only being 
trialled in children aged 10 and above. One clinician also commented that the 
schedules tend to be quite “negative” in their language rather than focusing on 
protective factors. 
 
Discussion 
Overall, the instruments that make up the FACE-CARAS were reliably rated by 
clinicians with minimal training. The high reliability is probably partly due to the 
clear anchor points provided. A small number of paired ratings showed poor 
agreement. This may have been due to the complexity of the clinical presentation or 
erratic rater behaviour. Further research would be required to elicit the cause of non-
concordant ratings. The qualitative feedback supports earlier work (Daniel et al., 
2013) indicating that the system, even in paper format, was acceptable, although there 
were some suggestions for improvement. Internal reliability-consistency was 
generally high, as indexed by Cronbach’s alphas. The inter-rater reliability was 
generally comparable with those for previously trialled risk instruments (Vincent, 
Guy, Fusco, & Gershenson, 2012). However, whilst high alpha values tend to suggest 
items are tapping into the same construct (unidimensionality) they may also hint that 
certain items may be redundant or dependant on responses to other questions. Thus, 
future studies may highlight where the schedules can be shortened with no loss of 
information. 
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The FEDS and LDVAS schedules demonstrated almost perfect agreement 
between raters. In the FEDS, this may be accounted for, to some extent, by the 
majority of the questions only having two rating options compared to the other 
schedules that for the most part use a 4-point rating scale combined with the majority 
of questions being objective (i.e. temperature) rather than subjective (i.e. therapeutic 
engagement). Although we have limited data on the LDVAS, preliminary data 
suggests high inter-rater reliability. This would need to be confirmed by further 
exploration in an LD population. Forensic CAMHS patients received higher ratings 
on the CRAY violence risk schedules compared to generic CAMHS, suggesting some 
discriminative validity. 
The OPEN schedule demonstrated low variance in rater responses, 
highlighting the presence of ‘floor’ effects. This is a test targeting issue in that many 
in-patients did not show evidence of risk factors at the times the ratings were 
conducted. Thus, limited information about participants scoring at the lower end of 
the rating scales was available. However, this may be appropriate in this setting as in-
patient clinical staff should only be alerted to factors which are likely to significantly 
increase the risks to the patient and others. In contrast, the raters of the SECURE 
schedule often produced ‘non-zero’ ratings for their clients suggesting better test 
targeting due to the higher level of perceived risks. The risk profiles on the SECURE 
do appear to be potentially able to discriminate between individuals, given the reliable 
scoring and the reasonable spread of item scores, which is likely to equate to 
acceptable levels of test information. There may have been some selection bias due to 
clinicians selecting patients they deemed more risky, which may have increased the 
reliability of the codings. The suite may be less useful for ‘low risk’ cases. Only one 
patient refused participation which may have reduced the risk of response, if not 
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selection bias. Clinician training for the FACE-CARAS should focus on items that 
demonstrated a low kappa score or they should be removed from future iterations of 
the suite. 
The main limitation of the study was that the FACE-CARAS could not be 
implemented in its intended electronic format. An electronic ‘Beta’ version of the 
system has now been produced and is undergoing post-marketing testing. One 
concern raised was that the pilot was only being trialled in children aged 10 and 
above. If the FACE-CARAS is to be used in practice in younger children it is 
important that it is validated in this population which was not part of the remit of this 
study. We did not explore the impact of clinical experience on reliability of ratings in 
this study; although there were no indications from our small sample that experience 
effected reliability. The number of pairings was small for some schedules and 
although this is acceptable for a pilot study, it limits generalizability. Our relatively 
small sample from one UK-based mental health Trust may not generalise to other 
healthcare settings. Ideally work streams should also be developed that will gather 
evidence to support or refute the concurrent, and ultimately, the predictive validity of 
the individual tools that make up the risk assessment system. 
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Key Practitioner Message: 
 A flexible system of structured clinical risk assessment tools was acceptable 
for routine use in a variety of CAMHS settings. 
 The individual schedules that made up the risk assessment system 
demonstrated acceptable to high levels of inter-rater reliability and internal 
reliability-consistency. 
 Minimal training in the system (one hour orientation session) was required to 
achieve inter-rater reliability. 
 
 
 
 
Table 1 
 
 
Schedule No. of 
paired 
ratings 
No. 
items 
in 
the 
scale 
Median 
kappa 
value 
for 
ratings 
Inter-
Quartile 
Range 
for 
kappas 
Minimum 
kappa for 
a patient 
rating 
Maximum 
kappa for 
a patient 
rating 
Mean 
quadratically 
weighted 
kappa for 
patient 
ratings 
Internal 
reliability- 
consistency 
(Cronbach’s 
alpha 
Risk Profile 44 8 0.73 0.59 0.00 1.00 0.66** 0.77 
CASH 12 17 0.73 0.24 0.00 1.00 0.67** 0.90 
CRAY 22 28 0.71 0.38 0.00 0.93 0.66** 0.92 
FEDS 10 26 0.98 0.05 0.79 1.00 0.96*** 0.73 
LDVAS 2 20 0.82 0.35 0.65 1.00 0.82*** 0.98 
OPEN 8 7 0.53 0.49 0.00 0.89 0.44* 0.68 
ScRAP 5 23 0.76 0.41 0.00 1.00 0.60* 0.89 
SECURE 7 9 0.74 0.21 0.29 1.00 0.70** 0.81 
SHARP20 7 28 0.75 0.36 0.17 0.85 0.65** 0.96 
VAS 8 20 0.72 0.45 0.00 0.88 0.59* 0.91 
 
 
